1
|
Tilz R, Feher M, Vogler J, Bode K, Duta A, Ortolan A, Lopez LD, Küchler M, Mamaev R, Lyan E, Sommer P, Braun M, Sciacca V, Demming T, Maslova V, Kuck KH, Heeger CH, Eitel C, Popescu SS. Venous Vascular Closure System Versus Figure-of-Eight Suture Following Atrial Fibrillation Ablation - The STYLE-AF Study. Europace 2024:euae105. [PMID: 38647070 DOI: 10.1093/europace/euae105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Accepted: 04/09/2024] [Indexed: 04/25/2024] Open
Abstract
BACKGROUND Simplified ablation technologies for pulmonary vein isolation (PVI) are increasingly performed worldwide. One of the most common complications following PVI are vascular access-related complications. Lately, venous closure systems (VCS) were introduced into clinical practice, aiming to reduce the time of bedrest, to increase the patients' comfort and to reduce vascular access-related complications. AIMS To compare the safety and efficacy of using a VCS to achieve haemostasis following single shot PVI to the actual standard of care (figure-of-eight suture and manual compression (MC)). METHODS This is a prospective, multicentre, randomized, controlled, open-label trial performed at 3 German centres. Patients were randomized 1:1 to undergo haemostasis either by means of VCS (VCS group) or of a figure-of-eight suture and MC (F8 group). The primary efficacy endpoint was the time to ambulation, while the primary safety endpoint was the incidence of major periprocedural adverse events until hospital discharge. RESULTS A total of 125 patients were randomized. The baseline characteristics were similar between the groups. The VCS group showed a shorter time to ambulation (109.0 (82.0, 160.0) vs. 269.0 (243.8, 340.5) min; p<0.001), shorter time to haemostasis (1 (1, 2) vs. 5 (2, 10) min; p<0.001) and shorter time to discharge eligibility (270 (270, 270) vs. 340 (300, 458) min; p<0.001). No major vascular access related complication was reported in either group. A trend towards a lower incidence of minor vascular access related complications on the day of procedure was observed in the VCS group (7 (11.1%) vs. 15 (24.2%); p=0.063) as compared to the control group. CONCLUSION Following AF ablation, the use of a VCS results in a significantly shorter time to ambulation, time to haemostasis and time to discharge eligibility. No major vascular access related complications were identified. The use of MC and a figure-of-eight suture showed a trend towards a higher incidence of minor vascular access related complications.
Collapse
Affiliation(s)
- R Tilz
- Department of Rhythmology, University Heart Center, Luebeck, Germany
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany
| | - M Feher
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - J Vogler
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - K Bode
- Heart Center of Leipzig, Leipzig, Germany
| | - A Duta
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - A Ortolan
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | | | - M Küchler
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - R Mamaev
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - E Lyan
- University Medical Center of Schleswig-Holstein - Campus Kiel, Kiel, Germany
| | - Philipp Sommer
- Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany
| | - M Braun
- Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany
| | - V Sciacca
- Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany
| | - T Demming
- University Medical Center of Schleswig-Holstein - Campus Kiel, Kiel, Germany
| | - V Maslova
- University Medical Center of Schleswig-Holstein - Campus Kiel, Kiel, Germany
| | - K H Kuck
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - C-H Heeger
- Department of Rhythmology, University Heart Center, Luebeck, Germany
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany
| | - C Eitel
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| | - S S Popescu
- Department of Rhythmology, University Heart Center, Luebeck, Germany
| |
Collapse
|
2
|
Wienemann H, Meincke F, Vach M, Heeger CH, Meyer A, Spangenberg T, Kuck KH, Ghanem A. Outcome of a polymer-free drug-coated coronary stent in bifurcation lesions-Pilot registry with serial OCT imaging. Herz 2023; 48:292-300. [PMID: 35397659 DOI: 10.1007/s00059-022-05109-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2021] [Revised: 02/24/2022] [Accepted: 03/16/2022] [Indexed: 11/04/2022]
Abstract
BACKGROUND Polymer-free and carrier-free drug-coated stents (DCS) represent a novel therapeutic option for the treatment of coronary artery disease. The objective of this pilot registry is to evaluate the safety and efficacy of DCS implantation in bifurcation lesions. METHODS Overall, 23 consecutive patients with 24 lesions received a Biolimus A9-coated DCS for coronary bifurcation lesions. Patients were examined with quantitative coronary angiography (QCA) and optical coherence tomography (OCT) at 3-6 months of follow-up. RESULTS A total of 23 patients with 24 bifurcation lesions were included in this study. Nine (33.3%) lesions of eight patients revealed angiographical target lesion failure due to in-stent restenosis (ISR). In total, 19 patients with 20 bifurcation lesions were suitable for OCT analysis. A total of 2936 struts were analyzed and 14 struts (0.47%) were classified as malapposed. The mean luminal area (mm2) was not different in lesions with ISR vs. lesions with no ISR (5.07 ± 2.0 vs. 5.73 ± 1.34, p = 0.39) at follow-up. Lesions with ISR showed higher mean neointimal burden (27.11 ± 10.59 vs. 13.93 ± 9.16%, respectively; p = 0.009). All of the patients who presented with significant ISR required percutaneous re-intervention. CONCLUSIONS We observed a high rate of DCS ISR in bifurcation lesions, possibly related to increased inflammation and neoatherosclerosis. The small size of the study warrants careful interpretation of our results. Larger trials are necessary to expand knowledge of these findings.
Collapse
Affiliation(s)
- Hendrik Wienemann
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
- Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany.
| | - Felix Meincke
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany
- Department of Cardiology, Asklepios Klinik Altona, Hamburg, Germany
| | - Marius Vach
- Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany
| | - Christian-Hendrik Heeger
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany
- Department of Rhythmology, University Heart Center Lübeck, UKSH Lübeck, Lübeck, Germany
| | - Annika Meyer
- Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany
| | - Tobias Spangenberg
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany
- Department of Cardiology, Asklepios Klinik Altona, Hamburg, Germany
| | - Karl Heinz Kuck
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany
- Department of Rhythmology, University Heart Center Lübeck, UKSH Lübeck, Lübeck, Germany
| | - Alexander Ghanem
- Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany
- Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany
- Department of Cardiology, Asklepios Klinik Nord, Hamburg, Germany
| |
Collapse
|
3
|
Lemes C, Rottner L, Heeger CH, Maurer T, Reissmann B, Ouyang F, Mathew S, Metzner A, Schlueter M, Kuck KH. Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Perimitral flutter and atrial fibrillation may occur in patients with prior surgical mitral valve (MV) repair or replacement and can be challenging for percutaneous catheter ablation.
Objective
This study sought to determine the feasibility, acute success and durability of catheter ablation of atrial fibrillation or atrial tachycardia by way of a mitral isthmus line (MIL) or an anterior line (AL).
Methods
A total of 81 patients (49 males, mean age 62±11 years) with prior MV replacement (n=30) or repair (n=51) underwent creation of a MIL (n=34) and/or an AL (n=72). Control group patients without prior surgery were matched 1:1 with the valve group (MIL, n=34; AL, n=72).
Results
Acute bidirectional block of the MIL was successfully achieved in 24/34 cases and of the AL in 64/72 patients with prior MV surgery. In the control group, acute bidirectional block was achieved in 31/34 MIL patients and 65/72 AL patients. In terms of durability, the MIL valve subgroup showed the poorest results (probability of long-term failure 2.224, as opposed to 0.605 in the MIL control subgroup; hazard ratio [HR]=0.27, 95% confidence interval [CI], 0.11–0.65; p=0.004). In the AL subgroups, long-term outcomes were similar (probability of failure in AL valve subgroup 0.844 vs. AL control subgroup 1.03; HR=1.22, 95% CI, 0.66–2.26; p=0.523).
Conclusions
Percutaneous creation of MIL and AL is feasible and safe in patients with prior MV replacement/repair. Because of poor long-term outcomes, MIL creation appears not advisable in patient with prior MV surgery.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Lemes
- University Heart Center , Luebeck , Germany
| | - L Rottner
- The University Medical Center Hamburg-Eppendorf , Hamburg , Germany
| | - C H Heeger
- University Heart Center , Luebeck , Germany
| | - T Maurer
- Asklepios Clinic St. Georg , Hamburg , Germany
| | - B Reissmann
- The University Medical Center Hamburg-Eppendorf , Hamburg , Germany
| | - F Ouyang
- The University Medical Center Hamburg-Eppendorf , Hamburg , Germany
| | - S Mathew
- University Hospital Giessen and Marburg, Cardiology , Giessen , Germany
| | - A Metzner
- The University Medical Center Hamburg-Eppendorf , Hamburg , Germany
| | | | | |
Collapse
|
4
|
Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F, Kuniss M, Aryana A, Miyazaki S, Chun JC, Kuck KH, Dahme T, Steven D, Sommer P, Tilz RR. Repeat procedures and reconnection rates after cryoballoon PVI with phrenic nerve injury. Europace 2022. [DOI: 10.1093/europace/euac053.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Aims
Cryoballoon (CB) based pulmonary vein isolation (PVI) is an effective treatment for atrial fibrillation (AF). The most frequent complication during CB-based PVI is right-sided phrenic nerve injury which is leading to premature abortion of the freeze cycle. Here we analysed repeat procedures and reconnection rates after CB-based PVI and phrenic nerve injury in a large-scale population. Due to the fact that the freezing process was prematurely interrupted the data may offer unique findings in optimizing the CB dosing protocols.
Methods and Results
In the YETI registry a total of 17356 patients underwent CB-based PVI in 33 centers and 731 (4.2%) patients experienced phrenic nerve injury. A total of 111 / 731 (15.2%) patients received a repeat procedure utilizing a 3D mapping system due to AF recurrence. In 94/111 (84.7%) of patients data on repeat procedures was available. During their initial PVI procedures, phrenic nerve injury occurred during treatment of RSPV (n=80), RIPV (n=13) and LSPV (n=1). A total of 89/94 (94.7%) target PVs have been isolated during the initial PVI (RSPV: 75/80, 94%; RIPV: 13/13; 100%; LSPV: 1/1; 100%). The mean freezing time was 127±46s and the mean minimal temperature was -49±7°C. During the repeat procedures 67 of initially 89 isolated PVs showed persistent isolation (75%, for RSPV: 55/75; 73%; RIPV: 11/13; 85%; LSPV: 1/1; 100%).
Conclusion
In patients initially treated by CB-based PVI with interruption of the freezing due to phrenic nerve injury, a high rate of durable isolated PVs has been detected at repeat procedures. Our data may help to identify the optimal dosing protocol in CB-based PVI procedures
Collapse
Affiliation(s)
- CH Heeger
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - C Sohns
- Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| | - A Pott
- Heart Clinic Ulm, Ulm, Germany
| | - A Metzner
- The University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - O Inaba
- Japanese Red Cross Saitama Hospital, Saitama, Japan
| | | | - M Kuniss
- Kerckhoff Clinic, Bad Nauheim, Germany
| | - A Aryana
- Mercy Heart Institute, Sacramento, United States of America
| | - S Miyazaki
- Tsuchiura Kyodo Hospital, Tsuchiura, Japan
| | - JC Chun
- CCB am Markus Hospital, Frankfurt am Main, Germany
| | - KH Kuck
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - T Dahme
- Heart Clinic Ulm, Ulm, Germany
| | - D Steven
- Cologne University Hospital - Heart Center, Cologne, Germany
| | - P Sommer
- Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| | - RR Tilz
- University of Luebeck, Medical clinic II, Luebeck, Germany
| |
Collapse
|
5
|
Schleberger R, Metzner A, Kuck KH, Andresen D, Willems S, Hoffmann E, Deneke T, Eckardt L, Brachmann J, Hochadel M, Senges J, Rillig A. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality – insights from the German Ablation Registry. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Data on the optimal treatment strategy for antiarrhythmic drug therapy (AAD) after atrial fibrillation (AF) catheter ablation are inconsistent. While AAD potentially stabilizes sinus rhythm, it also increases the patients' treatment burden.
Methods
Patients from the prospective German Ablation Registry (n=3275) discharged with or without AAD after AF catheter ablation were compared regarding long-term success, cardiovascular events and patient reported outcome.
Results
In patients with paroxysmal AF (n=2138) recurrence and rehospitalization rates did not differ when discharged with (n=1051) or without (n=1087) AAD (recurrence: adjusted odds ratio (OR) 1.13, 95% confidence interval (CI) [0.95–1.35]; rehospitalization: OR 1.08, 95% CI [0.90–1.30]). The reablation rate was higher and reduced treatment satisfaction was reported more often in those discharged with AAD (reablation: OR 1.30, 95% CI [1.05–1.61]; reduced treatment satisfaction: OR 1.76, 95% CI [1.20–2.58]).
Similar rates of recurrences, rehospitalisations, reablations and treatment satisfaction were found in patients with persistent AF (n=1137) discharged with (n=641) or without (n=496) AAD (recurrence: OR 1.22, 95% CI [0.95–1.56]; rehospitalization: OR 1.16, 95% CI [0.90–1.50]; reablation: OR 1.21, 95% CI [0.91–1.61]; treatment satisfaction: OR 1.24, 95% CI [0.74–2.08]).
The incidence of cardiovascular events and mortality did not differ at follow-up in paroxysmal and persistent AF patients discharged with or without AAD.
Conclusion
The rates of recurrences, cardiovascular events and mortality did not differ between patients discharged with or without AAD after AF catheter ablation. However, AAD should be considered carefully in patients with paroxysmal AF, in whom it was associated with a higher reablation rate and reduced treatment satisfaction.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- R Schleberger
- University Heart & Vascular Center Hamburg, Hamburg, Germany
| | - A Metzner
- University Heart & Vascular Center Hamburg, Hamburg, Germany
| | | | | | - S Willems
- Asklepios Clinic St. Georg, Hamburg, Germany
| | | | - T Deneke
- Heart Center Bad Neustadt, Bad Neustadt a. d. Saale, Germany
| | - L Eckardt
- Muenster University Hospital, Muenster, Germany
| | | | - M Hochadel
- Stiftung Institut fuer Herzinfarktforschung, Ludwigshafen, Germany
| | - J Senges
- Stiftung Institut fuer Herzinfarktforschung, Ludwigshafen, Germany
| | - A Rillig
- University Heart & Vascular Center Hamburg, Hamburg, Germany
| |
Collapse
|
6
|
Beyersdorf F, Bauer T, Freemantle N, Walther T, Frerker C, Herrmann E, Bleiziffer S, Möllmann H, Landwehr S, Ensminger S, Bekeredjian R, Cremer J, Kuck KH, Fujita B, Gummert J, Müller L, Beckmann A, Hamm CW. Five-year outcome in 18 010 patients from the German Aortic Valve Registry. Eur J Cardiothorac Surg 2021; 60:1139-1146. [PMID: 33942061 DOI: 10.1093/ejcts/ezab216] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 03/17/2021] [Accepted: 03/24/2021] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES To determine the 5-year outcome in patients treated by isolated transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (sAVR)-a prospective observational cohort study. METHODS A total of 18 010 patients were included (n = 8942 TAVI and n = 9068 sAVR) in the German Aortic Valve Registry (GARY) who were treated in 2011 and 2012 at 92 sites in central Germany. Eligible patients with TAVI and sAVR were matched using propensity scores in a nearest-neighbour approach. Patients with repeat procedures or unequivocal indication for one treatment option (e.g. frailty) were excluded (n = 4785 for TAVI and n = 2 for sAVR). This led to 13 223 patients (4157 TAVI and 9066 sAVR) as an unmatched subcohort. The main outcome measure was the 5-year all-cause mortality. RESULTS TAVI patients were significantly older (80.9 ± 6.1 vs 68.5 ± 11.1 years, P < 0.001), had a higher Society of Thoracic Surgeons (STS) score (6.3 ± 4.9 vs 2.6 ± 3.0, P < 0.001) and a higher 5-year all-cause mortality (49.8% vs 16.5%, P < 0.0001). There was no major difference in in-hospital stroke, in-hospital myocardial infarction, or temporary and chronic dialysis. In the propensity score-matched group (n = 3640), there were 763 deaths (41.9%) among 1820 TAVI patients compared with 552 (30.3%) among 1820 treated with sAVR during the 5-year follow-up (hazard ratio 1.51, 95% confidence interval 1.35-1.68; P < 0.0001). New pacemaker implantation was performed in 448 patients (24.6%) after TAVI and in 201 (11.0%) after sAVR (P < 0.0001). CONCLUSIONS The 5-year follow-up data show that TAVI patients were significantly older and had a higher STS score than sAVR patients. After propensity score matching, TAVI with early-generation prosthesis was associated with significantly higher 5-year all-cause mortality than sAVR.
Collapse
Affiliation(s)
- Friedhelm Beyersdorf
- Department of Cardiovascular Surgery, University Heart Center Freiburg-Bad Krozingen, Freiburg, Germany.,Medical Faculty of the Albert-Ludwigs-University Freiburg, Freiburg, Germany
| | - Timm Bauer
- Department of Cardiology, Sana Klinikum Offenbach, Offenbach, Germany
| | - Nick Freemantle
- Comprehensive Clinical Trial Unit, University College London, London, UK
| | - Thomas Walther
- Department of Thoracic, Cardiac and Thoracic Vascular Surgery, University of Frankfurt, Frankfurt, Germany
| | - Christian Frerker
- Department of Cardiology, University Hospital Cologne, University of Cologne, Faculty of Medicine, Cologne, Germany
| | - Eva Herrmann
- German Center for Cardiovascular Research (DZHK), Partner Site Rhein/Main, Germany.,Institute of Biostatistics and Mathematical Modelling, Goethe University Frankfurt, Frankfurt, Germany
| | - Sabine Bleiziffer
- Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| | - Helge Möllmann
- Department of Internal Medicine I, St.-Johannes-Hospital, Dortmund, Germany
| | - Sandra Landwehr
- BQS Institute for Quality and Patient Safety, Düsseldorf, Germany
| | - Stephan Ensminger
- Department of Cardiac Surgery, University Hospital Lübeck, Lübeck, Germany
| | | | - Jochen Cremer
- Department of Cardiac and Vascular Surgery, University Hospital Kiel, Kiel, Germany
| | - Karl Heinz Kuck
- Department of Cardiology, Angiology, Intensive Care, University Hospital Lübeck, Lübeck, Germany
| | - Buntaro Fujita
- Department of Cardiac Surgery, University Hospital Lübeck, Lübeck, Germany
| | - Jan Gummert
- Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| | - Lisa Müller
- BQS Institute for Quality and Patient Safety, Düsseldorf, Germany
| | - Andreas Beckmann
- Germany Society for Thoracic and Cardiovascular Surgery, Berlin, Germany
| | - Christian W Hamm
- Department of Cardiology, Campus Kerckhoff University of Giessen, Bad Nauheim, Germany
| | | |
Collapse
|
7
|
Schenker N, Hashiguchi N, Maurer T, Lemes C, Rottner L, Reissmann B, Rillig A, Kuck KH, Ouyang F, Mathew S. P1361Impact of radiation/chemotherapy for breast cancer on the electroanatomic features in patients receiving catheter ablation for left atrial arrhythmia. Europace 2020. [DOI: 10.1093/europace/euaa162.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Atrial fibrillation (AF) is a common cardiac arrhythmia and catheter ablation a viable treatment option for patients with AF. Extensive left atrial (LA) scars, frequently seen in patients with persistent AF, can limit its efficacy. Radiation for breast cancer treatment is known to have serious long-term effects (e.g. fibrosis) on the targeted tissue. At the same time, chemotherapy often leads to organ dysfunction. We sought to examine the effects of radiation and chemotherapy on the electroanatomic features of the LA in patients who received catheter ablation for left atrial arrhythmias with prior breast cancer treatment.
Methods and Results
We compared 38 patients (mean age 68.4 ± 7.1 years) who underwent catheter ablation for LA arrhythmia and had a previous diagnosis of breast cancer with 38 patients (mean age 65.4 ± 7.3 years) without breast cancer who formed our control group. LA scar area, as well as its distribution was measured during the electrophysiology (EP) study and graded according to the Utah classification.
The existence of LA scarring did not differ significantly between both groups (71.1% vs. 76.3%, p = 0.602). LA scar area (excluding PVs) was 107.5cm2 ± 19.0cm2 in the breast cancer group compared to 110.1cm2 ± 18.5cm2 in the control group (p = 0.536). The distribution of the scar area revealed no significant difference between both groups, however an involvement of the anterior wall was common (65.8% vs. 73.7%; p = 0.454). We further investigated whether the location of breast cancer had an impact on the LA scar development of the patients in our study cohort. Here, we found no significant difference in the amount of LA scarring when comparing patients with left-sided breast cancer to patients with right-sided breast cancer (66.7% vs. 73.9%). In a sub-analysis patients with breast cancer and persistent AF showed a non-significant trend towards greater LA scar areas (17.4cm2 vs. 6.8cm2) in comparison to patients of the control group with similar LA volumes.
The patient’s age (>65 years) was the only independent predictor for greater LA scarring we could identify. Neither former radiotherapy, nor chemotherapy showed a positive correlation with greater LA scarring.
Conclusion
There is no change in the distribution as well as an increase of the extent of LA scars after thoracic irradiation and/or chemotherapy. A trend towards greater LA scar areas was seen in patients with breast cancer and persistent AF. The patient’s age was identified as an independent predictor for LA scar development.
Collapse
Affiliation(s)
- N Schenker
- Asklepios Clinic St. Georg, Hamburg, Germany
| | | | - T Maurer
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - L Rottner
- University Heart Center Hamburg, Hamburg, Germany
| | - B Reissmann
- University Heart Center Hamburg, Hamburg, Germany
| | - A Rillig
- University Heart Center Hamburg, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - F Ouyang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - S Mathew
- Justus-Liebig University of Giessen, Giessen, Germany
| |
Collapse
|
8
|
Nickenig G, Von Bardeleben RS, Schaefer U, Kuck KH, Vahanian A, Juliard JM, Latib A, Baldus S, Maisano F, Hausleiter J. P4716One-year outcomes of the tri-repair study assessing cardioband tricuspid valve reconstruction system for patients with severe tricuspid regurgitation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Severe tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options.
Objectives
We report the one-year outcomes of the Cardioband™ Tricuspid Valve Reconstruction System in the treatment of severe functional TR in 30 patients enrolled in the TRI-REPAIR study.
Methods
Between October 2016 and July 2017, 30 patients were enrolled in this single-arm, multicenter, prospective study. Patients were diagnosed with severe, symptomatic TR in the absence of untreated left-heart disease and deemed inoperable because of unacceptable risk for open-heart surgery by the local heart team. Clinical, functional, and echocardiographic data were prospectively collected before and up to one year post-procedure. An independent core lab assessed all echocardiographic data and an independent clinical event committee adjudicated the safety events.
Results
Mean patient age was 75 years, 73% were females, 23% had ischemic heart disease, and 93% had atrial fibrillation. At baseline, 83% were in NYHA Class III-IV, 63% had edema, and LVEF was 58%. Technical success was 100%. Through one year, one patient had a reintervention and exited the study. Five patients died of which one was device-related. Between baseline and one year (paired analyses), echocardiography showed average reductions of annular septolateral diameter of 16% (44mm vs. 37mm; p<0.0001), PISA EROA of 49% (0.73cm2 vs. 0.37cm2, p=0.0037), and mean vena contracta of 30% (1.2cm vs. 0.9cm, p=0.0046). Clinical assessment showed that at one year 78% of patients were in NYHA Class I-II (p=0.0003). Six minute walk distance improved by 42m (p=0.0525). Kansas City Cardiomyopathy Questionnaire score improved by 19 points (p=0.0009). Edema was absent in 70% of the patients.
Conclusions
These results show that the Cardioband tricuspid system performs as intended and appears to be safe in patients with symptomatic and severe functional TR. At one year significant reduction of TR through a sustained decrease of annular dimensions, improvements in heart failure symptoms, quality of life, and exercise capacity were observed. Further studies are warranted to validate these initial promising results.
Acknowledgement/Funding
Edwards Lifescieinces
Collapse
Affiliation(s)
| | | | - U Schaefer
- University Heart Center Hamburg, Hamburg, Germany
| | - K H Kuck
- St. George Hospital, Hamburg, Germany
| | | | | | - A Latib
- San Raffaele Scientific Institute, Milan, Italy
| | - S Baldus
- University Hospital Cologne, Cologne, Germany
| | - F Maisano
- University Hospital Zurich, Zurich, Switzerland
| | | |
Collapse
|
9
|
Chmelevsky M, Budanova M, Zubarev S, Potyagaylo D, Sohns C, Lemes C, Kivelitz D, Metzner A, Kuck KH. P6566Noninvasive Panoramic Mapping of Phase Singularities with Signal Complexity Analysis in Patients with Persistent Atrial Fibrillation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
An assessment of positive outcome probability of ablation therapy based on the comprehensive signal complexity analysis is a promising working hypothesis while electrocardiographic imaging (ECGI) can detect and visualize zones of phase singularities (PS) associated with stable sources of atrial fibrillation (AF).
Methods
Ten consecutive patients with persistent AF (three female, median (min–max) – 63.5 (45–75) years) underwent ECGI using “Amycard 01C EP lab” system with cardiac MRI (1.5-T Magnetom Avanto) followed by pulmonary vein isolation. Each T-Q segment with a length >800 ms during AF was processed to find PS. Sites with rotations around stable pivot points were considered as PS and then marked and visualized on the reconstructed anatomical 3D atrial model. Finally, a signal complexity cluster analysis was performed to define and depict phase-aggregation zones.
Results
ECGI analysis identified a total number of 410 PS, with 196 (47.8%) occurring in the LA and 214 (52.2%) in the RA. The median (25–75% IQR) number of revealed PS per patient was n=20 (14–30) for RA and n=20 (11–22) for the LA. The majority of the PS in the LA was located on the inferior wall n=66 (min-max 1–17). In eight patients, comprehensive signal complexity analysis revealed stability of phase-clustered zones over time. The mean number (min-max) of PS in a clustered area was 10 (6–15). In two patients, PS were distributed disordered on the entire LA and RA surface.
Distribution of phase singularities
Conclusions
This is the first clinical study demonstrating signal complexity analysis capability of clustering noninvasively mapped PS and relating them to specific atrial anatomical regions. Thereby obtained clusters may be a potential zones of conduction block, and could contribute to a better understanding of the temporal AF complexity.
Collapse
Affiliation(s)
- M Chmelevsky
- Almazov National Medical Research Center, Saint-Petersburg, Russian Federation
| | - M Budanova
- Almazov National Medical Research Center, Saint-Petersburg, Russian Federation
| | - S Zubarev
- Almazov National Medical Research Center, Saint-Petersburg, Russian Federation
| | - D Potyagaylo
- Karlsruhe Institut of Technology (IBT), Karlsruhe, Germany
| | - C Sohns
- Heart and Diabetes Center NRW, Department of Electrophysiology, Bad Oeynhausen, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Kivelitz
- Asklepios Clinic St. Georg, Department of Radiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
10
|
Bahlmann E, van der Schalk H, Ghanem A, Kuck KH, Kivelitz D, Laßner D, Terborg C. [Brain infarction as initial manifestation of eosinophilic myocarditis]. Nervenarzt 2019; 89:200-203. [PMID: 28246755 DOI: 10.1007/s00115-017-0302-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- E Bahlmann
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland.
| | - H van der Schalk
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland
| | - A Ghanem
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland
| | - K H Kuck
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland
| | - D Kivelitz
- Abteilung für Radiologie, Asklepios Klinik St. Georg, Lohmühlenstrasse 5, 20099, Hamburg, Deutschland
| | - D Laßner
- Institut Kardiale Diagnostik und Therapie, Moltkestrasse 31, 12203, Berlin, Deutschland
| | - C Terborg
- Abteilung für Neurologie, Asklepios Klinik St. Georg, Lohmühlenstrasse 5, 20099, Hamburg, Deutschland
| |
Collapse
|
11
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Wyn Davies D, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Interv Card Electrophysiol 2019; 50:1-55. [PMID: 28914401 PMCID: PMC5633646 DOI: 10.1007/s10840-017-0277-z] [Citation(s) in RCA: 72] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Hugh Calkins
- Johns Hopkins Medical Institutions, Baltimore, MD, USA.
| | | | - Riccardo Cappato
- Humanitas Research Hospital, Arrhythmias and Electrophysiology Research Center, Milan, Italy
- Department of Biomedical Sciences, Humanitas University, Milan, Italy
- IRCCS, Humanitas Clinical and Research Center, Milan, Italy
| | | | - Eduardo B Saad
- Hospital Pro-Cardiaco and Hospital Samaritano, Botafogo, Rio de Janeiro, Brazil
| | | | - Joseph G Akar
- Yale University School of Medicine, New Haven, CT, USA
| | - Vinay Badhwar
- West Virginia University School of Medicine, Morgantown, WV, USA
| | - Josep Brugada
- Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain
| | - John Camm
- St. George's University of London, London, UK
| | - Peng-Sheng Chen
- Indiana University School of Medicine, Indianapolis, IN, USA
| | | | | | | | | | - D Wyn Davies
- Imperial College Healthcare NHS Trust, London, UK
| | - John D Day
- Intermountain Medical Center Heart Institute, Salt Lake City, UT, USA
| | | | | | - Luigi Di Biase
- Albert Einstein College of Medicine, Montefiore-Einstein Center for Heart & Vascular Care, Bronx, NY, USA
| | | | | | | | | | - Sabine Ernst
- Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, UK
| | - Guilherme Fenelon
- Albert Einstein Jewish Hospital, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | - Elaine Hylek
- Boston University School of Medicine, Boston, MA, USA
| | - Warren M Jackman
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Jose Jalife
- University of Michigan, Ann Arbor, MI, USA
- The National Center for Cardiovascular Research Carlos III (CNIC), Madrid, Spain
- CIBERCV, Madrid, Spain
| | - Jonathan M Kalman
- Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
| | - Josef Kautzner
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Hans Kottkamp
- Hirslanden Hospital, Department of Electrophysiology, Zurich, Switzerland
| | | | | | - Richard Lee
- Saint Louis University Medical School, St. Louis, MO, USA
| | - Thorsten Lewalter
- Department of Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Munich, Germany
| | | | - Laurent Macle
- Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Canada
| | | | - Francis E Marchlinski
- Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- University of Pennsylvania School of Medicine, Philadelphia, PA, USA
| | | | - Hiroshi Nakagawa
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Andrea Natale
- St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, TX, USA
| | - Stanley Nattel
- Montreal Heart Institute, Montreal, QC, Canada
- Université de Montréal, Montreal, QC, Canada
- McGill University, Montreal, QC, Canada
- University Duisburg-Essen, Essen, Germany
| | - Ken Okumura
- Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan
| | | | - Evgeny Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russia
| | | | - Prashanthan Sanders
- Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
- Royal Adelaide Hospital, Adelaide, Australia
| | | | | | - Claudio Tondo
- Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Milan, Italy
- Department of Cardiovascular Sciences, University of Milan, Milan, Italy
| | | | - Atul Verma
- Southlake Regional Health Centre, University of Toronto, Toronto, ON, Canada
| | | | | |
Collapse
|
12
|
Latib A, Nickenig G, Kuck KH, Baldus S, Schueler R, Messika-Zeitoun D, La Canna G, Agricola E, Kreidel F, Zuber M, Huntgeburth M, Vahanian A, Maisano F. 3073Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.3073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- A Latib
- San Raffaele Hospital (IRCCS), Milan, Italy
| | - G Nickenig
- University Hospital Bonn, Department of Cardiology, Bonn, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - S Baldus
- Cologne University Hospital - Heart Center, Cologne, Germany
| | - R Schueler
- University Hospital Bonn, Department of Cardiology, Bonn, Germany
| | | | - G La Canna
- San Raffaele Hospital (IRCCS), Milan, Italy
| | - E Agricola
- San Raffaele Hospital (IRCCS), Milan, Italy
| | - F Kreidel
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - M Zuber
- University Hospital Zurich, Zurich, Switzerland
| | - M Huntgeburth
- Cologne University Hospital - Heart Center, Cologne, Germany
| | - A Vahanian
- Hospital Bichat-Claude Bernard, Paris, France
| | - F Maisano
- University Hospital Zurich, Zurich, Switzerland
| |
Collapse
|
13
|
Heeger CH, Metzner A, Schlueter M, Rillig A, Mathew S, Fink T, Reissmann B, Lemes C, Maurer T, Santoro F, Schmidt T, Ghanem A, Frerker C, Kuck KH, Ouyang F. 2117Cerebral protection during catheter ablation of ventricular tachycardia in patients with ischemic heart disease. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.2117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - M Schlueter
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Schmidt
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Ghanem
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Frerker
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
14
|
Alessandrini H, Kreidel F, Wohlmuth P, Schlueter M, Schewel J, Schewel D, Schmidt T, Frerker C, Kuck KH. P1754Anatomical, morphological, and haemodynamic predictors of transmitral pressure gradient greater than or equal to 5 mmHg after MitraClip implantation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H Alessandrini
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - F Kreidel
- University Medical Center of Mainz, Mainz, Germany
| | - P Wohlmuth
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - M Schlueter
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - J Schewel
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - D Schewel
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - T Schmidt
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C Frerker
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| |
Collapse
|
15
|
Heeger CH, Rillig A, Geisler D, Fink T, Mathew S, Tilz RR, Reissmann B, Lemes C, Maurer T, Santoro F, Alessandrini H, Dotz I, Metzner A, Kuck KH, Ouyang F. P4827Wide area left atrial appendage isolation in patients non responding to pulmonary vein isolation: Benefit, risk and prevention of thromboembolism. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C H Heeger
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Geisler
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - R R Tilz
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - H Alessandrini
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - I Dotz
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
16
|
Jilek C, Brachmann J, Lewalter TH, Kuck KH, Andresen D, Willems SG, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. 366No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure - results from German Ablation registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- C Jilek
- Peter-Osypka-Heart Centre, Hospital for Internal Medicine Munich South, Munich, Germany
| | - J Brachmann
- Coburg Hospital, Department of Cardiology, Angiology, and Pneumology, Second Medical Clinic, Coburg, Germany
| | - T H Lewalter
- Peter-Osypka-Heart Centre, Hospital for Internal Medicine Munich South, Munich, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Andresen
- Vivantes Klinik Am Urban, Department of Cardiology and Internal Medicine, Berlin, Germany
| | - S G Willems
- University Heart Center Hamburg, Department of Electrophysiology, Hamburg, Germany
| | - S G Spitzer
- Praxisklinik Herz und Gefäße, Dresden, Germany
| | - F Straube
- Municipal Hospital of Munich, Heart Center Munich-Bogenhausen, Munich, Germany
| | - B Schumacher
- Westpfalz Hospital, Department of Cardiology, Pneumology, Angiology and Intensive Care, Kaiserslautern, Germany
| | - L Eckardt
- University Medical Center, Division of Electrophysiology, Department of Cardiology and Angiology, Münster, Germany
| | - D Danilovic
- Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany
| | - D Thomas
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - M Hochadel
- Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany
| | - J Senges
- Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany
| |
Collapse
|
17
|
Von Bardeleben RS, Nickenig G, Hausleiter J, Schaefer U, Kuck KH, Vahanian A. 30726 month follow up results from the european transcatheter tricuspid valve repair multicenter trial. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.3072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- R S Von Bardeleben
- University Medical Center of Mainz, Dept. of Cardiology, Angiology, Intensive Care, Mainz, Germany
| | - G Nickenig
- University Hospital Bonn, Dept. of Cardiology, Bonn, Germany
| | - J Hausleiter
- Ludwig-Maximilians University, Großhadern/Innenstadt, Munich, Germany
| | - U Schaefer
- University Medical Center Hamburg Eppendorf, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - A Vahanian
- Hospital Bichat-Claude Bernard, Dept. of Cardiology, Paris, France
| |
Collapse
|
18
|
Romanov A, Pokushalov E, Shabanov V, Mikheenko I, Stenin I, Schwartz Y, Ben-Haim SA, Kuck KH. 742 Real-time gap detection during atrial fibrillation ablation using novel dielectric sensing system: results of the Durable-I clinical trial. Europace 2018. [DOI: 10.1093/europace/euy015.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Romanov
- State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
| | - E Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
| | - V Shabanov
- State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
| | - I Mikheenko
- State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
| | - I Stenin
- State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
| | | | | | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| |
Collapse
|
19
|
Heeger CH, Metzner A, Rillig A, Mathew S, Fink T, Reissmann B, Lemes C, Maurer T, Santoro F, Schmidt T, Frerker C, Ghanem A, Kuck KH, Ouyang F. 997Embolic debris captured by a cerebral protection system during catheter ablation of ventricular tachycardia in patients with ischemic heart disease. Europace 2018. [DOI: 10.1093/europace/euy015.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Schmidt
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Frerker
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Ghanem
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
20
|
Heeger CH, Tscholl V, Wissner E, Fink T, Bellmann B, Mathew S, Reissmann B, Lemes C, Maurer T, Goldmann B, Landmesser U, Ouyang F, Kuck KH, Rillig A, Metzner A. P278Acute efficacy, safety and clinical outcomes utilizing the second-generation cryoballoon for pulmonary vein isolation in patients with previously implanted cardiac devices for continuous atrial monito. Europace 2018. [DOI: 10.1093/europace/euy015.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - V Tscholl
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - E Wissner
- University of Illinois at Chicago, Cardiology, Chicago, United States of America
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Bellmann
- Charite - Campus Benjamin Franklin, Cardiology, Berlin, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Goldmann
- Asklepios Klinik Harburg, Cardiology, Hamburg, Germany
| | - U Landmesser
- Charite - Campus Benjamin Franklin, Cardiology, Berlin, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
21
|
Rottner L, Schmidt T, Dotz I, Lemes C, Heeger CH, Fink T, Mathew S, Reissmann B, Rexha E, Riedl J, Frerker C, Ouyang F, Kuck KH, Metzner A, Maurer T. P1212The clip and the tip: Long-term clinical outcome after ablation of atrial fibrillation in patients with MitraClip. Europace 2018. [DOI: 10.1093/europace/euy015.694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- L Rottner
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - T Schmidt
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - I Dotz
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - E Rexha
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - J Riedl
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C Frerker
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| |
Collapse
|
22
|
Mathew S, Maurer T, Lemes C, Heeger C, Reissmann B, Santoro F, Metzner A, Rillig A, Kuck KH, Ouyang F. P296Ablation of ventricular tachycardia in patients with structural heart disease and electrical storm. Europace 2018. [DOI: 10.1093/europace/euy015.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- S Mathew
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - C Heeger
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Hamburg, Germany
| |
Collapse
|
23
|
Santoro F, Heeger CH, Heeger CH, Reissmann B, Reissmann B, Maurer T, Maurer T, Fink T, Fink T, Lemes C, Lemes C, Mathew S, Mathew S, Rillig A, Rillig A, Ouyang F, Ouyang F, Kuck KH, Kuck KH, Metzner A, Metzner A. P1155Left atrial appendage flow velocity is an independent predictor of recurrence in patients referred for cryoablation of atrial fibrillation. Europace 2018. [DOI: 10.1093/europace/euy015.641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
24
|
Santoro F, Mathew S, Heeger CH, Fink T, Maurer T, Lemes C, Reissmann B, Rillig A, Metzner A, Kuck KH, Ouyang F. P293Prognostic significance of Ventricular Tachycardia clustering after catheter ablation in non-ischemic dilated cardiomyopathy. Europace 2018. [DOI: 10.1093/europace/euy015.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
25
|
Santoro F, Metzner A, Reissmann B, Maurer T, Fink T, Heeger CH, Lemes C, Mathew S, Ouyang F, Kuck KH, Rillig A. P365First in-human experience with ablation index to perform left atrial anterior line in patients with persistent atrial fibrillation. Europace 2018. [DOI: 10.1093/europace/euy015.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
26
|
Heeger CH, Rillig A, Tilz RR, Fink T, Mathew S, Reissmann B, Lemes C, Maurer T, Santoro F, Inaba O, Alessandrini H, Dotz I, Metzner A, Kuck KH, Ouyang F. 520Wide area left atrial appendage isolation for atrial fibrillation therapy: Long-term succes and incidence of stroke and thrombus formation. Europace 2018. [DOI: 10.1093/europace/euy015.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - R R Tilz
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - O Inaba
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - H Alessandrini
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - I Dotz
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
27
|
Jilek C, Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. 1012No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry. Europace 2018. [DOI: 10.1093/europace/euy015.561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C Jilek
- Peter-Osypka-Heart Centre, Hospital for Internal Medicine Munich South, Munich, Germany
| | - J Brachmann
- Coburg Hospital, Department of Cardiology, Angiology, and Pneumology, Second Medical Clinic, Coburg, Germany
| | - T Lewalter
- Peter-Osypka-Heart Centre, Hospital for Internal Medicine Munich South, Munich, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Andresen
- Vivantes Klinikum Am Urban, Department of Cardiology and Internal Medicine, Berlin, Germany
| | - S Willems
- University Heart Center Hamburg, Department of Electrophysiology, Hamburg, Germany
| | - S G Spitzer
- Praxisklinik Herz und Gefäße, Dresden, Germany
| | - F Straube
- Munich Municipal Hospital Group, Heart Center Munich- Bogenhausen, Munich, Germany
| | - B Schumacher
- Westpfalz Hospital, Department of Cardiology, Pneumology, Angiology and Intensive Care, Kaiserslautern, Germany
| | - L Eckardt
- University Medical Center, Division of Electrophysiology, Department of Cardiology and Angiology, Münster, Germany
| | - D Danilovic
- Stiftung Institut für Herzinfarktforschung (IHF), Ludwigshafen, Germany
| | - D Thomas
- University of Heidelberg, Department of Cardiology, Heidelberg, Germany
| | - M Hochadel
- Stiftung Institut für Herzinfarktforschung (IHF), Ludwigshafen, Germany
| | - J Senges
- Stiftung Institut für Herzinfarktforschung (IHF), Ludwigshafen, Germany
| |
Collapse
|
28
|
Sohns C, Heeger CH, Volkmer M, Metzner A, Nuernberg JH, Buchwalsky G, Ventura R, Reinhardt A, Jansen H, Kuck KH, Hebe JH, Ouyang F, Siebels JH. P298VT therapy in patients with noncompaction cardiomyopathy. Europace 2018. [DOI: 10.1093/europace/euy015.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C Sohns
- Elektrophysiologie Bremen, Bremen, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - M Volkmer
- Elektrophysiologie Bremen, Bremen, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Hamburg, Germany
| | | | | | - R Ventura
- Elektrophysiologie Bremen, Bremen, Germany
| | | | - H Jansen
- Elektrophysiologie Bremen, Bremen, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - J H Hebe
- Elektrophysiologie Bremen, Bremen, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Hamburg, Germany
| | | |
Collapse
|
29
|
Heeger CH, Bellmann B, Fink T, Mathew S, Reissmann B, Lemes C, Maurer T, Santoro F, Sultan A, Plenge T, Ouyang F, Kuck KH, Metzner A, Steven D, Rillig A. P286Safety and long-term clinical success of pulmonary vein isolation utilizing the second generation cryoballoon in patients over 75 years of age: A multicenter study. Europace 2018. [DOI: 10.1093/europace/euy015.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C H Heeger
- University of Luebeck, Medical clinic II, Luebeck, Germany
| | - B Bellmann
- University of Cologne, Cardiology, Cologne, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Sultan
- University of Cologne, Cardiology, Cologne, Germany
| | - T Plenge
- University of Cologne, Cardiology, Cologne, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Steven
- University of Cologne, Cardiology, Cologne, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
30
|
Sohns C, Rottner L, Reissmann B, Heeger CH, Lemes CH, Fink T, Volkmer M, Ventura R, Wohlmuth P, Mathew S, Metzner A, Ouyang F, Kuck KH, Maurer T. P835The force awakens: one year clinical outcome after pulmonary vein isolation using the novel ThermoCool SmartTouch Surround Flow catheter. Europace 2018. [DOI: 10.1093/europace/euy015.439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C Sohns
- Elektrophysiologie Bremen, Bremen, Germany
| | - L Rottner
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - C H Heeger
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - C H Lemes
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - M Volkmer
- Elektrophysiologie Bremen, Bremen, Germany
| | - R Ventura
- Elektrophysiologie Bremen, Bremen, Germany
| | - P Wohlmuth
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Hamburg, Germany
| |
Collapse
|
31
|
Heeger CH, Bellmann B, Fink T, Mathew S, Reissmann B, Lemes C, Maurer T, Santoro F, Sultan A, Plenge T, Ouyang F, Kuck KH, Metzner A, Steven D, Rillig A. P284Long-term clinical success of pulmonary vein isolation utilizing the second generation cryoballoon in patients with persistent atrial fibrillation: A multicenter study. Europace 2018. [DOI: 10.1093/europace/euy015.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C H Heeger
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Bellmann
- University of Cologne, Cardiology, Cologne, Germany
| | - T Fink
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Sultan
- University of Cologne, Cardiology, Cologne, Germany
| | - T Plenge
- University of Cologne, Cardiology, Cologne, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| | - D Steven
- University of Cologne, Cardiology, Cologne, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany
| |
Collapse
|
32
|
Fink T, Schlueter M, Heeger CH, Rillig A, Lemes C, Maurer T, Reissmann B, Rottner L, Santoro F, Tilz RR, Mathew S, Ouyang F, Kuck KH, Metzner A. P398Acute and long-term outcomes of epicardial left atrial appendage ligation with the second generation LARIAT device: A European high-volume electrophysiology center experience. Europace 2018. [DOI: 10.1093/europace/euy015.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- T Fink
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - M Schlueter
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C-H Heeger
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - A Rillig
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - C Lemes
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - T Maurer
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - B Reissmann
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - L Rottner
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - F Santoro
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - R R Tilz
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - S Mathew
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - F Ouyang
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - K H Kuck
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| | - A Metzner
- Asklepios Clinic St. Georg, Cardiology, Hamburg, Germany
| |
Collapse
|
33
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMS(N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace 2018; 20:157-208. [PMID: 29016841 PMCID: PMC5892164 DOI: 10.1093/europace/eux275] [Citation(s) in RCA: 332] [Impact Index Per Article: 55.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Affiliation(s)
- Hugh Calkins
- From the Johns Hopkins Medical Institutions, Baltimore, MD
| | | | - Riccardo Cappato
- Humanitas Research Hospital, Arrhythmias and Electrophysiology Research Center, Milan, Italy (Dr. Cappato is now with the Department of Biomedical Sciences, Humanitas University, Milan, Italy, and IRCCS, Humanitas Clinical and Research Center, Milan, Italy)
| | | | - Eduardo B Saad
- Hospital Pro-Cardiaco and Hospital Samaritano, Botafogo, Rio de Janeiro, Brazil
| | | | | | - Vinay Badhwar
- West Virginia University School of Medicine, Morgantown, WV
| | - Josep Brugada
- Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain
| | - John Camm
- St. George’s University of London, London, United Kingdom
| | | | | | | | | | | | - D Wyn Davies
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - John D Day
- Intermountain Medical Center Heart Institute, Salt Lake City, UT
| | | | | | - Luigi Di Biase
- Albert Einstein College of Medicine, Montefiore-Einstein Center for Heart & Vascular Care, Bronx, NY
| | | | | | | | | | - Sabine Ernst
- Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, United Kingdom
| | - Guilherme Fenelon
- Albert Einstein Jewish Hospital, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | - Elaine Hylek
- Boston University School of Medicine, Boston, MA
| | - Warren M Jackman
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Jose Jalife
- University of Michigan, Ann Arbor, MI, the National Center for Cardiovascular Research Carlos III (CNIC) and CIBERCV, Madrid, Spain
| | - Jonathan M Kalman
- Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
| | - Josef Kautzner
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Hans Kottkamp
- Hirslanden Hospital, Department of Electrophysiology, Zurich, Switzerland
| | | | | | - Richard Lee
- Saint Louis University Medical School, St. Louis, MO
| | - Thorsten Lewalter
- Department of Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Munich, Germany
| | | | - Laurent Macle
- Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Canada
| | | | - Francis E Marchlinski
- Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
| | | | - Hiroshi Nakagawa
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Andrea Natale
- Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin, TX
| | - Stanley Nattel
- Montreal Heart Institute and Université de Montréal, Montreal, Canada, McGill University, Montreal, Canada, and University Duisburg-Essen, Essen, Germany
| | - Ken Okumura
- Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan
| | | | - Evgeny Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russia
| | | | - Prashanthan Sanders
- Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
| | | | | | - Claudio Tondo
- Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
| | | | - Atul Verma
- Southlake Regional Health Centre, University of Toronto, Toronto, Canada
| | | | | |
Collapse
|
34
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Cosedis Nielsen J, Curtis AB, Davies DW, Day JD, d’Avila A, (Natasja) de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2018; 20:e1-e160. [PMID: 29016840 PMCID: PMC5834122 DOI: 10.1093/europace/eux274] [Citation(s) in RCA: 681] [Impact Index Per Article: 113.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Affiliation(s)
- Hugh Calkins
- From the Johns Hopkins Medical Institutions, Baltimore, MD
| | | | - Riccardo Cappato
- Humanitas Research Hospital, Arrhythmias and Electrophysiology Research Center, Milan, Italy (Dr. Cappato is now with the Department of Biomedical Sciences, Humanitas University, Milan, Italy, and IRCCS, Humanitas Clinical and Research Center, Milan, Italy)
| | | | - Eduardo B Saad
- Hospital Pro-Cardiaco and Hospital Samaritano, Botafogo, Rio de Janeiro, Brazil
| | | | | | - Vinay Badhwar
- West Virginia University School of Medicine, Morgantown, WV
| | - Josep Brugada
- Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain
| | - John Camm
- St. George's University of London, London, United Kingdom
| | | | | | | | | | | | - D Wyn Davies
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - John D Day
- Intermountain Medical Center Heart Institute, Salt Lake City, UT
| | | | | | - Luigi Di Biase
- Albert Einstein College of Medicine, Montefiore-Einstein Center for Heart & Vascular Care, Bronx, NY
| | | | | | | | | | - Sabine Ernst
- Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, United Kingdom
| | - Guilherme Fenelon
- Albert Einstein Jewish Hospital, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | - Elaine Hylek
- Boston University School of Medicine, Boston, MA
| | - Warren M Jackman
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Jose Jalife
- University of Michigan, Ann Arbor, MI, the National Center for Cardiovascular Research Carlos III (CNIC) and CIBERCV, Madrid, Spain
| | - Jonathan M Kalman
- Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
| | - Josef Kautzner
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Hans Kottkamp
- Hirslanden Hospital, Department of Electrophysiology, Zurich, Switzerland
| | | | | | - Richard Lee
- Saint Louis University Medical School, St. Louis, MO
| | - Thorsten Lewalter
- Department of Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Munich, Germany
| | | | - Laurent Macle
- Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Canada
| | | | - Francis E Marchlinski
- Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
| | | | - Hiroshi Nakagawa
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Andrea Natale
- Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX
| | - Stanley Nattel
- Montreal Heart Institute and Université de Montréal, Montreal, Canada, McGill University, Montreal, Canada, and University Duisburg-Essen, Essen, Germany
| | - Ken Okumura
- Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan
| | | | - Evgeny Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russia
| | | | - Prashanthan Sanders
- Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
| | | | | | - Claudio Tondo
- Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
| | | | - Atul Verma
- Southlake Regional Health Centre, University of Toronto, Toronto, Canada
| | | | | |
Collapse
|
35
|
Sultan A, Lüker J, Andresen D, Kuck KH, Hoffmann E, Brachmann J, Hochadel M, Willems S, Eckardt L, Lewalter T, Senges J, Steven D. Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry. Sci Rep 2017; 7:16678. [PMID: 29192223 PMCID: PMC5709464 DOI: 10.1038/s41598-017-16938-6] [Citation(s) in RCA: 96] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Accepted: 11/20/2017] [Indexed: 11/09/2022] Open
Abstract
Catheter ablation (CA) for atrial fibrillation (AF) has emerged as a widespread first or second line treatment option. However, up to 45% of patients (pts) show recurrence of AF within 12 month after CA. We present prospective multicenter registry data comparing characteristics of pts with and without recurrence of AF within the first year after CA. This study comprises all pts with complete follow-up one year after CA (1-y-FU; n = 3679). During 1y-FU in 1687 (45.9%) pts recurrence of AF occurred. The multivariate analysis revealed female sex and AF type prior to the procedure as predictors for AF recurrence. Furthermore, comorbidities such as valvular heart disease and renal failure as well as an early AF relapse were also predictors of AF recurrence during 1-y-FU. However, despite an AF recurrence rate of 45.9%, the majority of these pts (72.4%) reported a significant alleviation of clinical symptoms. In conclusion in pts with initially successful CA for AF female sex, AF type, in-hospital AF relapse and comorbidities such as renal failure and valvular heart disease are independent predictors for AF recurrence during 1-y-FU. However, the majority of pts deemed their interventions as successful with significant reduction of symptoms irrespective of AF.
Collapse
Affiliation(s)
- A Sultan
- University Heart Center Cologne, Dept. of Electrophysiology, Cologne, Germany.
| | - J Lüker
- University Heart Center Cologne, Dept. of Electrophysiology, Cologne, Germany
| | | | - K H Kuck
- Asklepios Hosp. St. Georg Hamburg, Hamburg, Germany
| | | | | | | | - S Willems
- University Heart Center Hamburg, Dept. of Electrophysiology, Hamburg, Germany
| | - L Eckardt
- University Hosp. Münster, Dept. of Electrophysiology, Münster, Germany
| | - T Lewalter
- Dept. of Medicine-Cardiology, P. Osypka Heart Center Munich, Munich, Germany
| | - J Senges
- IHF Ludwigshafen, Ludwigshafen, Germany
| | - D Steven
- University Heart Center Cologne, Dept. of Electrophysiology, Cologne, Germany
| |
Collapse
|
36
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot N(N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14:e275-e444. [PMID: 28506916 PMCID: PMC6019327 DOI: 10.1016/j.hrthm.2017.05.012] [Citation(s) in RCA: 1293] [Impact Index Per Article: 184.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2017] [Indexed: 02/07/2023]
Affiliation(s)
- Hugh Calkins
- Johns Hopkins Medical Institutions, Baltimore, MD
| | | | - Riccardo Cappato
- Humanitas Research Hospital, Arrhythmias and Electrophysiology Research Center, Milan, Italy (Dr. Cappato is now with the Department of Biomedical Sciences, Humanitas University, Milan, Italy, and IRCCS, Humanitas Clinical and Research Center, Milan, Italy)
| | | | - Eduardo B. Saad
- Hospital Pro-Cardiaco and Hospital Samaritano, Botafogo, Rio de Janeiro, Brazil
| | | | | | - Vinay Badhwar
- West Virginia University School of Medicine, Morgantown, WV
| | - Josep Brugada
- Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain
| | - John Camm
- St. George’s University of London, London, United Kingdom
| | | | | | | | | | | | - D. Wyn Davies
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - John D. Day
- Intermountain Medical Center Heart Institute, Salt Lake City, UT
| | | | | | - Luigi Di Biase
- Albert Einstein College of Medicine, Montefiore-Einstein Center for Heart & Vascular Care, Bronx, NY
| | | | | | | | | | - Sabine Ernst
- Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, United Kingdom
| | - Guilherme Fenelon
- Albert Einstein Jewish Hospital, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | - Elaine Hylek
- Boston University School of Medicine, Boston, MA
| | - Warren M. Jackman
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Jose Jalife
- University of Michigan, Ann Arbor, MI, the National Center for Cardiovascular Research Carlos III (CNIC) and CIBERCV, Madrid, Spain
| | - Jonathan M. Kalman
- Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
| | - Josef Kautzner
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Hans Kottkamp
- Hirslanden Hospital, Department of Electrophysiology, Zurich, Switzerland
| | | | | | - Richard Lee
- Saint Louis University Medical School, St. Louis, MO
| | - Thorsten Lewalter
- Department of Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Munich, Germany
| | | | - Laurent Macle
- Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Canada
| | | | - Francis E. Marchlinski
- Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
| | | | - Hiroshi Nakagawa
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Andrea Natale
- Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin, TX
| | - Stanley Nattel
- Montreal Heart Institute and Université de Montréal, Montreal, Canada, McGill University, Montreal, Canada, and University Duisburg-Essen, Essen, Germany
| | - Ken Okumura
- Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan
| | | | - Evgeny Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russia
| | | | - Prashanthan Sanders
- Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
| | | | | | - Claudio Tondo
- Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
| | | | - Atul Verma
- Southlake Regional Health Centre, University of Toronto, Toronto, Canada
| | | | | |
Collapse
|
37
|
Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard JM, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schäfer U, Schofer J, Schueler R, Tang G, Vahanian A, Webb JG, Yzeiraj E, Maisano F, Leon MB. The International Multicenter TriValve Registry. JACC Cardiovasc Interv 2017; 10:1982-1990. [DOI: 10.1016/j.jcin.2017.08.011] [Citation(s) in RCA: 139] [Impact Index Per Article: 19.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 08/03/2017] [Accepted: 08/08/2017] [Indexed: 11/26/2022]
|
38
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm 2017; 33:369-409. [PMID: 29021841 PMCID: PMC5634725 DOI: 10.1016/j.joa.2017.08.001] [Citation(s) in RCA: 175] [Impact Index Per Article: 25.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Key Words
- AAD, antiarrhythmic drug
- AF, atrial fibrillation
- AFL, atrial flutter
- Ablation
- Anticoagulation
- Arrhythmia
- Atrial fibrillation
- Atrial flutter
- Atrial tachycardia
- CB, cryoballoon
- CFAE, complex fractionated atrial electrogram
- Catheter ablation
- LA, left atrial
- LAA, left atrial appendage
- LGE, late gadolinium-enhanced
- LOE, level of evidence
- MRI, magnetic resonance imaging
- OAC, oral anticoagulation
- RF, radiofrequency
- Stroke
- Surgical ablation
Collapse
Affiliation(s)
- Hugh Calkins
- Johns Hopkins Medical Institutions, Baltimore, MD
| | | | - Riccardo Cappato
- Humanitas Research Hospital, Arrhythmias and Electrophysiology Research Center, Milan, Italy.,Department of Biomedical Sciences, Humanitas University, Milan, Italy.,IRCCS, Humanitas Clinical and Research Center, Milan, Italy
| | | | - Eduardo B Saad
- Hospital Pro-Cardiaco and Hospital Samaritano, Botafogo, Rio de Janeiro, Brazil
| | | | | | - Vinay Badhwar
- West Virginia University School of Medicine, Morgantown, WV
| | - Josep Brugada
- Cardiovascular Institute, Hospital Clínic, University of Barcelona, Catalonia, Spain
| | - John Camm
- St. George's University of London, London, United Kingdom
| | | | | | | | | | | | - D Wyn Davies
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - John D Day
- Intermountain Medical Center Heart Institute, Salt Lake City, UT
| | | | | | - Luigi Di Biase
- Albert Einstein College of Medicine, Montefiore-Einstein Center for Heart & Vascular Care, Bronx, NY
| | | | | | | | | | - Sabine Ernst
- Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, United Kingdom
| | - Guilherme Fenelon
- Albert Einstein Jewish Hospital, Federal University of São Paulo, São Paulo, Brazil
| | | | | | | | | | - Elaine Hylek
- Boston University School of Medicine, Boston, MA
| | - Warren M Jackman
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Jose Jalife
- University of Michigan, Ann Arbor, MI, the National Center for Cardiovascular Research Carlos III (CNIC) and CIBERCV, Madrid, Spain
| | - Jonathan M Kalman
- Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
| | - Josef Kautzner
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | - Hans Kottkamp
- Hirslanden Hospital, Department of Electrophysiology, Zurich, Switzerland
| | | | | | - Richard Lee
- Saint Louis University Medical School, St. Louis, MO
| | - Thorsten Lewalter
- Department of Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Munich, Germany
| | | | - Laurent Macle
- Montreal Heart Institute, Department of Medicine, Université de Montréal, Montréal, Canada
| | | | - Francis E Marchlinski
- Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
| | | | - Hiroshi Nakagawa
- Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
| | - Andrea Natale
- Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX
| | - Stanley Nattel
- Montreal Heart Institute and Université de Montréal, Montreal, Canada, McGill University, Montreal, Canada, and University Duisburg-Essen, Essen, Germany
| | - Ken Okumura
- Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan
| | | | - Evgeny Pokushalov
- State Research Institute of Circulation Pathology, Novosibirsk, Russia
| | | | - Prashanthan Sanders
- Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
| | | | | | - Claudio Tondo
- Cardiac Arrhythmia Research Center, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, University of Milan, Milan, Italy
| | | | - Atul Verma
- Southlake Regional Health Centre, University of Toronto, Toronto, Canada
| | | | | |
Collapse
|
39
|
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot N(N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. J Arrhythm 2017. [DOI: 10.1016/j.joa.2017.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
40
|
Bahlmann E, Cramariuc D, Minners J, Lønnebakken MT, Ray S, Gohlke-Baerwolf C, Nienaber CA, Jander N, Seifert R, Chambers JB, Kuck KH, Gerdts E. Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications. Eur Heart J Cardiovasc Imaging 2016; 18:404-412. [DOI: 10.1093/ehjci/jew159] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 07/05/2016] [Indexed: 01/16/2023] Open
|
41
|
Abstract
The new European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmia and the prevention of sudden cardiac death, recently published at the annual ESC meeting in London, contain an extensive update of the recommendations for the diagnostics, drug therapy, interventional and device therapy of ventricular arrhythmia. The new recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prophylaxis of sudden cardiac death can be seen as a focused update of the previously published guidelines. Pre-existing recommendations for catheter ablation of ventricular arrhythmias have been partly extensively expanded with respect to the results of recent clinical trials. The guideline committee also adapted their recommendations regarding the hereditary arrhythmia syndromes to the 2013 consensus report of the American Heart Association (AHA), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society (APHRS).
Collapse
Affiliation(s)
- T Fink
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland
| | - K H Kuck
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland
| | - A Metzner
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.
| | | |
Collapse
|
42
|
Straube F, Dorwarth U, Ammar-Busch S, Peter T, Noelker G, Massa T, Kuniss M, Ewertsen NC, Chun KRJ, Tebbenjohanns J, Tilz R, Kuck KH, Ouarrak T, Senges J, Hoffmann E. First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation. Europace 2015; 18:368-75. [DOI: 10.1093/europace/euv271] [Citation(s) in RCA: 58] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2015] [Accepted: 07/15/2015] [Indexed: 11/14/2022] Open
|
43
|
Bahlmann E, Kuck KH, Nienaber CA. [Athlete's heart and hypertrophic cardiomyopathy: contribution on clinical and morphologic differentiation]. Dtsch Med Wochenschr 2015; 140:1158-64. [PMID: 26230069 DOI: 10.1055/s-0041-102559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Hypertrophic cardiomyopathy (HCM) is a complex genetic disorder usually diagnosed in a young adult population. The diagnosis is based on echocardiographic identification of left ventricular hypertrophy, associated with a non-dilated hyperdynamic chamber in the absence of another cardiac or systemic disorder. The differentiation between HCM and physiological left ventricular hypertrophy (athlete`s heart) is essential: HCM is the main cause of exercise-induced sudden cardiac death in the young and especially in young athletes with overlapping features in Athlete's Heart or HCM. Differentiation between physiological left ventricular hypertrophy and HCM is challenging. Echocardiography allows detailed assessment of left ventricular structure and function which is fundamental. Additional genetic studies for identification of the broad HCM phenotype can be necessary to differentiate between Athlete's Heart and HCM.
Collapse
Affiliation(s)
- Edda Bahlmann
- Abteilung für Kardiologie, Asklepios Klinik St. Georg Hamburg
| | - Karl Heinz Kuck
- Abteilung für Kardiologie, Asklepios Klinik St. Georg Hamburg
| | | |
Collapse
|
44
|
Schaefer U, Zahn R, Abdel-Wahab M, Gerckens U, Linke A, Schneider S, Eggebrecht H, Sievert H, Figulla HR, Senges J, Kuck KH. Comparison of outcomes of patients with left ventricular ejection fractions ≤30% versus ≥30% having transcatheter aortic valve implantation (from the German Transcatheter Aortic Valve Interventions Registry). Am J Cardiol 2015; 115:656-63. [PMID: 25613664 DOI: 10.1016/j.amjcard.2014.12.019] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Revised: 12/01/2014] [Accepted: 12/01/2014] [Indexed: 11/16/2022]
Abstract
Transcatheter aortic valve implantation (TAVI) is rapidly evolving in Germany. Especially severe reduced left ventricular ejection fraction (LVEF) is known as a prominent risk factor for adverse outcome in open heart surgery. Thus, the data of the prospective multicenter German Transcatheter Aortic Valve Interventions Registry were analyzed for outcomes in patients with severe depressed LVEF. Data of 1,432 patients were consecutively collected after transcatheter aortic valve implantation. Patients were divided into 2 groups (A: LVEF ≤30%, n = 169, age 79.9 ± 6.7 years, logES 34.2 ± 17.8%; B: LVEF >30%, n = 1,263, age 82.0 ± 6.1 years, logES 18.9 ± 12.0%), and procedural success rates, New York Heart Association classification, and quality of life were compared at 30 days and 1 year, respectively. Technical success was achieved in 95.9% (A) and 97.6% (B). Survival and the New York Heart Association classification at 30 days demonstrated an excellent outcome in both groups. There was a significant improvement according to the self-assessment in health condition (0 to 100 scale) with a much larger gain in group A (28 vs 19 patients, p <0.0001). Nevertheless, low cardiac output syndrome (12.3% vs 5.9%, p <0.01) and resuscitation (10.4% vs 5.6%, p <0.05) were more frequently seen in group A, contributing to a higher mortality at 30 days (14.3% vs 7.2%) and 1 year (33.7% vs 18.1%, p <0.001). In conclusion, this real-world registry demonstrated a comparably high success rate for patients with severe reduced LVEF and an early improvement in functional status as demonstrated by substantial benefit, despite a doubled postprocedural mortality.
Collapse
Affiliation(s)
- Ulrich Schaefer
- Department of Cardiology, Asklepios Clinics Sankt Georg, Hamburg, Germany; Department of Cardiology, University Heart Center Eppendorf, Hamburg, Germany.
| | - Ralf Zahn
- Department of Cardiology, Heart Center Ludwigshafen, Ludwigshafen, Germany
| | | | - Ulrich Gerckens
- Department of Cardiology, Gemeinschaftskrankenhaus, Bonn, Germany
| | - Axel Linke
- Heart Center, University of Leipzig, Leipzig, Germany
| | | | | | - Horst Sievert
- Cardiovascular Center Frankfurt, Sankt Katharinen, Frankfurt am Main, Germany
| | | | - Jochen Senges
- Institute of Myocardial Infarction Research, Ludwigshafen, Germany
| | - Karl Heinz Kuck
- Department of Cardiology, Asklepios Clinics Sankt Georg, Hamburg, Germany
| |
Collapse
|
45
|
Affiliation(s)
- R R Tilz
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Lohmühlenstraße 5, 20099, Hamburg, Deutschland,
| | | |
Collapse
|
46
|
Maisano F, La Canna G, Latib A, Denti P, Taramasso M, Kuck KH, Colombo A, Alfieri O, Guidotti A, Messika-Zeitoun D, Vahanian A. First-in-Man Transseptal Implantation of a “Surgical-Like” Mitral Valve Annuloplasty Device for Functional Mitral Regurgitation. JACC Cardiovasc Interv 2014; 7:1326-8. [DOI: 10.1016/j.jcin.2014.08.003] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2014] [Revised: 08/03/2014] [Accepted: 08/05/2014] [Indexed: 10/24/2022]
|
47
|
Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T, Dorian P, Huikuri H, Kim YH, Knight B, Marchlinski F, Ross D, Sacher F, Sapp J, Shivkumar K, Soejima K, Tada H, Alexander ME, Triedman JK, Yamada T, Kirchhof P, Lip GY, Kuck KH, Mont L, Haines D, Indik J, Dimarco J, Exner D, Iesaka Y, Savelieva I. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. J Arrhythm 2014. [DOI: 10.1016/j.joa.2014.08.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
|
48
|
Moser J, Kuck KH, Andresen D, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Brachmann J, Lewalter T, Hochadel M, Senges J, Willems S, Hoffmann BA. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry]. Dtsch Med Wochenschr 2014; 139:1923-8. [PMID: 25225860 DOI: 10.1055/s-0034-1387316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
BACKGROUND Catheter ablation (CA) for atrial fibrillation (AF) is an effective therapeutic option for the treatment of symptomatic drug-refractory AF. According to current guidelines, the prevention of stroke and embolism is the most important therapeutic goal in AF and the recommendations for anticoagulation (OAC) after successful CA are based upon the CHA2DS2-VASc-Score 3. The aim of this study was to evaluate the use of OAC in patients with a high risk for thromboembolic events 1 year after CA and to identify predictor variables for discontinuation of OAC. METHODS Between January 2007 and January 2010 13092 patients were enrolled in the study. A total of 52 German electrophysiological centers agreed to participate in this prospective multicenter registry. 41 centers included patients undergoing CA for AF. Analysis included patients who were discharged with OAC after CA and had a CHA2DS2-VASc-Score ≥ 2. A centralized 1 year follow-up (FU) was conducted via telephone. RESULTS 1300 patients fulfilled the inclusion criteria. One year after CA 51.8 % of these patients were on OAC. Factors significantly associated with discontinuation of OAC included no AF recurrence in FU (adjusted odds ratio (OR): 2.14, [95 % confidence interval (CI): 1.73-2.66], P < 0.001) and paroxysmal AF (OR: 1.53 [95 % CI: 1.29-1.81], P < 0.001). Factors associated with continuation of OAK were patient age (OR per 10 years: 0.79 [95 % CI: 0.68-0.91], P = 0.002), valvular heart disease (OR: 0.67 [95 % CI: 0.48-0.92], P = 0.013), an implanted pacemaker, defibrillator or a cardiac resynchronization therapy system (OR: 0.55 [95 % CI: 0.41-0.74], P < 0.001) and neurological events in hospital or during FU (OR: 0.40 [95 % CI: 0.18-0.88], P < 0.022). CONCLUSION Almost half of the patients with an indication for OAC are not adequately anticoagulated one year after CA for AF. Paroxysmal AF or freedom from AF is significantly associated with discontinuation of OAC.
Collapse
Affiliation(s)
- J Moser
- Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf
| | - K H Kuck
- Abteilung für Kardiologie, Asklepios Klinik St. Georg, Hamburg
| | - D Andresen
- Klinik für Innere Medizin - Kardiologie, Vivantes Klinikum Am Urban, Berlin
| | | | - E Hoffmann
- Klinik für Kardiologie und Intensivmedizin , Städtische Kliniken München, Klinikum Bogenhausen, München
| | - B Schumacher
- Medizinische Klinik II, Westpfalz-Klinikum, Kaiserslautern
| | - L Eckardt
- Abteilung Rhythmologie, Department für Kardiologie und Angiologie, Universitätsklinikum Münster, Münster
| | - J Brachmann
- II. Medizinische Klinik, Regiomed Klinik, Coburg
| | - T Lewalter
- Klinik für Kardiologie und internistische Intensivmedizin, Isar Herz Zentrum, Isar Kliniken GmbH, München
| | - M Hochadel
- Institut für Herzinfarktforschung, Ludwigshafen
| | - J Senges
- Institut für Herzinfarktforschung, Ludwigshafen
| | - S Willems
- Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf
| | - B A Hoffmann
- Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf
| |
Collapse
|
49
|
Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T, Dorian P, Huikuri H, Kim YH, Knight B, Marchlinski F, Ross D, Sacher F, Sapp J, Shivkumar K, Soejima K, Tada H, Alexander ME, Triedman JK, Yamada T, Kirchhof P, Lip GYH, Kuck KH, Mont L, Haines D, Indik J, Dimarco J, Exner D, Iesaka Y, Savelieva I. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 2014; 16:1257-83. [PMID: 25172618 DOI: 10.1093/europace/euu194] [Citation(s) in RCA: 136] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
|
50
|
Straube F, Dorwarth U, Vogt J, Kuniss M, Heinz Kuck K, Tebbenjohanns J, Garcia Alberola A, Chun KRJ, Souza JJ, Ouarrak T, Senges J, Brachmann J, Lewalter T, Hoffmann E. Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. ACTA ACUST UNITED AC 2014; 16:1434-42. [DOI: 10.1093/europace/euu162] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|